Figure 1
Figure 1. Development of pDC in lymphoid organs in DKO-hu mice. (A) Total live human cells (VLD-mCD45−hCD45+) from BM or spleen (SP) were analyzed for CD123 expression relative to BDCA2, CD4, HLA-DR, and CD3 expression. (B) pDCs in different lymphoid organs from the DKO-hu mice were analyzed. The number in each plot represents the percentage of CD4+CD123+ pDCs of total human CD45+ cells. Human PBMCs were used as a control. (C) Summarized data show average percentage of pDCs (CD3−CD4+CD123+ of total human CD45+ cells) in different lymphoid organs from DKO-hu mice at 12 weeks after transplantation (n = 7). (D) Total numbers of pDCs in each lymphoid organ are calculated as described in “Flow cytometry.” Error bars indicate SD (n = 7).

Development of pDC in lymphoid organs in DKO-hu mice. (A) Total live human cells (VLD-mCD45hCD45+) from BM or spleen (SP) were analyzed for CD123 expression relative to BDCA2, CD4, HLA-DR, and CD3 expression. (B) pDCs in different lymphoid organs from the DKO-hu mice were analyzed. The number in each plot represents the percentage of CD4+CD123+ pDCs of total human CD45+ cells. Human PBMCs were used as a control. (C) Summarized data show average percentage of pDCs (CD3CD4+CD123+ of total human CD45+ cells) in different lymphoid organs from DKO-hu mice at 12 weeks after transplantation (n = 7). (D) Total numbers of pDCs in each lymphoid organ are calculated as described in “Flow cytometry.” Error bars indicate SD (n = 7).

Close Modal

or Create an Account

Close Modal
Close Modal